Apr 07 2018 22 mins 64
In this episode we talk to Ed Boyer about Kratom, pharmacology, legal status, and discuss recent reports of adverse effects.
- Boyer et al Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)
- FDA response to Kratom
- Bradford Hill Criteria
Take Home Points:
- Kratom is an opioid agonist
- Patients should not mix Kratom with other substances
- Patients at risk of seizures should not use Kratom
- Kratom will not show up on a typical urine drug screen
The post Episode 41 Kratom: Friend or Foe first appeared on ToxNow.
